Publicaciones en colaboración con investigadoras/es de University of Lubeck (32)

2024

  1. Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial

    Cancers, Vol. 16, Núm. 6

2022

  1. A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression

    Cancers, Vol. 14, Núm. 15

  2. A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression

    Practical Radiation Oncology, Vol. 12, Núm. 4, pp. 354-362

  3. Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin

    Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 4, pp. 610-614

  4. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy

    Radiation Oncology, Vol. 17, Núm. 1

  5. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)

    BMC Cancer, Vol. 22, Núm. 1

  6. Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials

    Cancers, Vol. 14, Núm. 10

  7. Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy

    Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 3, pp. 428-439

2021

  1. Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials

    Radiation Oncology, Vol. 16, Núm. 1

2020

  1. Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial

    International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 780-789

  2. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis

    Trials, Vol. 21, Núm. 1

2019

  1. Patient-Reported Outcomes–Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression

    International Journal of Radiation Oncology Biology Physics, Vol. 105, Núm. 4, pp. 760-764

  2. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer

    Clinical Lung Cancer, Vol. 20, Núm. 4, pp. 322-329

  3. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: A matched-pair study of three prognostic patient subgroups

    Radiation Oncology, Vol. 13, Núm. 1

  2. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression

    Radiation Oncology, Vol. 13, Núm. 1

  3. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

    Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

  4. Comparison of two radiotherapy regimens for metastatic spinal cord compression: Subgroup analyses from a randomized trial

    Anticancer Research, Vol. 38, Núm. 2, pp. 1009-1015

  5. Prognostic factors and a survival score in patients irradiated for metastatic epidural spinal cord compression from urothelial carcinoma cancer of the bladder

    Anticancer Research, Vol. 38, Núm. 12, pp. 6841-6846

2017

  1. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): A multicenter phase 2 study

    BMC Cancer, Vol. 17, Núm. 1